Renal diseases can affect vitamin D activation, since the second step of vitamin D hydroxylation catalyzed by CYP27B1 takes place in kidney cells [7] and could decrease the usefulness vitamin D supplementation in cancer patients. The gene discussed is CYP27B1; the disease is kidney disorder.